Clinical trial
Celecoxib in Preventing Polyps in Patients Who Have Undergone Surgery for Stage…
NCT00087256 · NSABP Foundation Inc, Other · Terminated
Key facts
| NCT number | NCT00087256 |
|---|---|
| Title | Celecoxib in Preventing Polyps in Patients Who Have Undergone Surgery for Stage I Colon Cancer |
| Official title | Celecoxib Polyp Prevention Trial in Participants With Resected Stage I Colon Cancer |
| Lead sponsor | NSABP Foundation Inc, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug, Other |
| Interventions | Celecoxib, placebo |
| Enrollment | 18 |
| Start date | Jul 1, 2004 |
| Primary completion | Apr 1, 2006 |
| Completion | Apr 1, 2006 |
| First posted | Jul 12, 2004 |
| Last update posted | Jan 7, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: